Steris | STE - Cash And Equivalent


Steris reported $423.7M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
3M USD 5.24B 564M Dec/2025
Accuray USD 63.34M 5.93M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
CONMED USD 38.93M 4.99M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Dexcom USD 917.7M 918M Dec/2025
Ecolab USD 646.2M 1.31B Dec/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Fortive USD 375.5M 55.3M Dec/2025
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 371.77M 142.32M Sep/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
J&J USD 19.71B 1.48B Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
Olympus JPY 147.24B 93.98B Sep/2025
Orthofix International USD 62.86M 2.75M Sep/2025
Owens Minor USD 281.99M 249.15M Dec/2025
ResMed USD 1.42B 33.22M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025